Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.4 USD | +1.41% | -2.54% | +2.64% |
May. 24 | Declaration of Voting Results by DexCom, Inc | CI |
May. 24 | Declaration of Voting Results by DexCom, Inc | CI |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 50.65B |
---|---|---|---|---|---|
Net income 2024 * | 732M | Net income 2025 * | 911M | EV / Sales 2024 * | 12 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 994M | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
70.7
x | P/E ratio 2025 * |
57.7
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.62% |
Latest transcript on DexCom, Inc.
1 day | +1.41% | ||
1 week | -2.54% | ||
Current month | -0.02% | ||
1 month | +2.44% | ||
3 months | +10.45% | ||
6 months | +11.75% | ||
Current year | +2.64% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | +7.83% | - | |
1.04% | 14 M€ | -4.84% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 127.4 | +1.41% | 2,275,564 |
24-05-23 | 125.6 | -3.78% | 1,986,875 |
24-05-22 | 130.5 | -0.24% | 2,089,187 |
24-05-21 | 130.8 | +0.11% | 1,763,503 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.64% | 50.65B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B | |
-4.35% | 23.95B |
- Stock Market
- Equities
- DXCM Stock